2000多例女性免费两癌筛查结果分析

Analyze the free screening results of cervical cancer and breast cancer for more than 2000 females

中文关键词: 乳腺癌  子宫颈癌  妇科检查  彩超  液基薄层细胞检测  钼靶X线摄影

英文关键词: Breast cancer  Cervical cancer  Gynecological examination  Color Doppler ultrasound  Thin-cytologic test  Molybdenum target radiography

中文摘要:

      目的：总结分析2000多例女性免费两癌筛查的结果。方法：现对在本单位进行两癌筛查，即子宫颈癌和乳腺癌的女性展开研究，其中实施宫颈癌筛查的女性2424例，进行乳腺癌筛查的女性2422例，研究时间为2019年1月至2019年11月。分析两癌筛查的结果。结果：在宫颈癌的筛查中，检查结果异常的主要是生殖道感染和生殖系统良性疾病的女性，通过TCT检查发现其中近3.22%的女性显示异常，最终经阴道镜和组织病理检查显示其中有12例女性存在宫颈病变，占比率为0.5%；而在乳腺癌的筛查中，经乳腺超声、X线检查和组织病理检查显示仅有2例患者为浸润性导管癌，TNM分期显示为ⅡA期。结论：在两癌的筛查过程中，高危类型的女性癌症确诊的几率较高，并且在常见生殖系统疾病和乳腺疾病中的发病率也明显高于其他两个类型的女性，并且对于疾病知识的知晓率也明显较低。因此需加强对两癌健康知识的普及和宣传力度，提高群众的认知度和知晓率，从而采取有效的措施进行预防和干预，降低癌症的发生率。

英文摘要:

      Objective: To analyze the free screening results of cervical cancer and breast cancer for more than 2000 females.Methods: From January 2019 to November 2019,the females in our unit were treated for screening of cervical cancer and breast cancer.2424 females received the screening of cervical cancer and 2422 cases for screening of breast cancer. Screening results were probed. Results:In the screening of cervical cancer, reproductive tract infection or even benign systemic disease was mainly discovered. TCT(thin-cytologic test)indicated that nearly 3.22% of the females had the abnormality.0.5% of the females(12 cases)were confirmed with cervical lesions through colposcopy and histopathology examination. In the screening of breast cancer, only 2 cases had invasive ductal carcinoma(stage II A)through breast ultrasonography, X-ray and histopathology examination. Conclusion: In the screening process, the high-risk females may be possibly confirmed with higher incidences of reproductive system disease and breast disease, and lower awareness rate of illness knowledge. Therefore, the popularization and propaganda of health knowledge can increase their cognition degree and rate while the proper prevention and interventions may be applied for decreased rate of cervical cancer and breast cancer.